AMPK activators - Potential therapeutics for metabolic and other diseases

Acta Physiologica

Volumn 196, Issue 1, 2009, Pages 175-190

  Zhou, G ^a   Sebhat, I K ^a   Zhang, B B ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Activator; AMPK; Diabetes; Metabolic disease

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; BENZIMIDAZOLE DERIVATIVE; BERBERINE; BIGUANIDE DERIVATIVE; CARBOXYLIC ACID DERIVATIVE; CURCUMIN; ENZYME ACTIVATOR; FURANCARBOXYLIC ACID DERIVATIVE; GINSENOSIDE RH 2; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; KAINIC ACID; NUCLEOTIDE DERIVATIVE; PYRIDONE DERIVATIVE; QUERCETIN; RESVERATROL; THIAZOLIDINONE PT 1; THIENOPYRIDONE DERIVATIVE; TRITERPENOID; UNCLASSIFIED DRUG;

CONFERENCE PAPER; ENERGY METABOLISM; ENZYME ACTIVATION; EXERCISE; GLUCONEOGENESIS; GLUCOSE TRANSPORT; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID OXIDATION; LIPOGENESIS; LIVER; MOMORDICA CHARANTIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; SKELETAL MUSCLE;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ENERGY METABOLISM; ENZYME ACTIVATION; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; METABOLIC DISEASES; MOLECULAR STRUCTURE; MUSCLE, SKELETAL; PLANT EXTRACTS; SIGNAL TRANSDUCTION;

EID: 63849224233     PISSN: 17481708     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2009.01967.x     Document Type: Conference Paper

References (112)

1. Adiels, M., Olofsson, S.O., Taskinen, M.R. Borén, J. 2008. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol 28, 1225 1236.
2. Ahn, J., Lee, H., Kim, S., Park, J. Ha, T. 2008. The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways. Biochem Biophys Res Commun 373, 545 549.
3. Andreelli, F., Foretz, M., Knauf, C., Cani, P.D., Perrin, C., Iglesias, M.A., Pillot, B., Bado, A., Tronche, F., Mithieux, G., Vaulont, S., Burcelin, R. Viollet, B. 2006. Liver adenosine monophosphate-activated kinase-alpha2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin. Endocrinology 147, 2432 2441.
4. Assifi, M.M., Suchankova, G., Constant, S., Prentki, M., Saha, A.K. Ruderman, N.B. 2005. AMP-activated protein kinase and coordination of hepatic fatty acid metabolism of starved/carbohydrate-refed rats. Am J Physiol Endocrinol Metab 289, E794 E800.
5. Barthel, A., Schmoll, D., Krüger, K.D., Roth, R.A. Joost, H.G. 2002. Regulation of the forkhead transcription factor FKHR (FOXO1a) by glucose starvation and AICAR, an activator of AMP-activated protein kinase. Endocrinology 143, 3183 3186.
6. Baur, J.A., Pearson, K.J., Price, N.L., Jamieson, H.A., Lerin, C., Kalra, A., Prabhu, V.V., Allard, J.S., Lopez-Lluch, G., Lewis, K. et al. 2006. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444, 337 342.
7. Bergeron, R., Previs, S.F., Cline, G.W., Perret, P., Russell, R.R., III., Young, L.H. Shulman, G.I. 2001. Effect of 5-aminoimidazole-4-carboxamide-1- beta-d-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats. Diabetes 50, 1076 1082.
8. Birk, J.B. Wojtaszewski, J.F. 2006. Predominant alpha2/beta2/gamma3 AMPK activation during exercise in human skeletal muscle. J Physiol 577 (Pt 3 1021 1032.
9. Björnholm, M., Kawano, Y., Lehtihet, M. Zierath, J.R. 1997. Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes 46, 524 527.
10. Bleasby, K., Castle, J.C., Roberts, C.J., Cheng, C., Bailey, W.J., Sina, J.F., Kulkarni, A.V., Hafey, M.J., Evers, R., Johnson, J.M., Ulrich, R.G. Slatter, J.G. 2006. Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: a resource for investigations into drug disposition. Xenobiotica 36, 963 988.
11. Bratton, L.D., Auerbach, B., Choi, C., Dillon, L., Hanselman, J.C., Larsen, S.D., Lu, G., Olsen, K., Pfefferkorn, J.A., Robertson, A., Sekerke, C., Trivedi, B.K. Unangst, P.C. 2007. Discovery of pyrrole-based hepatoselective ligands as potent inhibitors of HMG-CoA reductase. Bioorg Med Chem 15, 5576 5589.
12. Brown, M.S. Goldstein, J.L. 2008. Selective versus total insulin resistance: a pathogenic paradox. Cell Metab 7, 95 96.
13. Brunmair, B., Staniek, K., Gras, F., Scharf, N., Althaym, A., Clara, R., Roden, M., Gnaiger, E., Nohl, H., Waldhausl, W. Furnsinn, C. 2004. Thiazolidinediones, like metformin, inhibit respiratory complex I. Diabetes 53, 1052 1059.
14. Brusq, J., Ancellin, N., Grondin, P., Guillard, R., Martin, S., Saintillan, Y. Issandou, M. 2006. Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine. J Lipid Res 47, 1281 1288.
15. Bruss, M.D., Arias, E.B., Lienhard, G.E. Cartee, G.D. 2005. Increased phosphorylation of Akt substrate of 160 kDa (AS160) in rat skeletal muscle in response to insulin or contractile activity. Diabetes 54, 41 50.
16. Buhl, E.S., Jesse, N., Pold, R., Ledet, T., Flyvbjerg, A., Pedersen, S.B., Pedersen, O., Schmitz, O. Lund, S. 2002. Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome. Diabetes 51, 2199 2206.
17. Carling, D. 2005. AMP-activated protein kinase: balancing the scales. Biochimie 87, 87 91.
18. Charton, J., Girault-Mizzi, S., Debreu-Fontaine, M., Foufelle, F., Hainault, I., Bizot-Espiard, J., Caignard, D. Sergheraert, C. 2006. Synthesis and biological evaluation of benzimidazole derivatives as potent AMP-activated protein kinase activators. Bioorg Med Chem 14, 4490 4518.
19. Clarke, P.R. Hardie, D.G. 1990. Regulation of HMG-CoA reductase: identification of the site phosphorylated by the AMP-activated protein kinase in vitro and in intact rat liver. EMBO J 9, 2439 2446.
20. Cool, B., Zinker, B., Chiou, W., Kifle, L., Cao, N., Perham, M., Dickinson, R., Adler, A., Gagne, G., Iyengar, R. et al. 2006. Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. Cell Metab 3, 403 416.
21. Corton, J.M., Gillespie, J.G., Hawley, S.A. Hardie, D.G. 1995. 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur J Biochem 229, 558 565.
22. Costford, S.R., Kavaslar, N., Ahituv, N., Chaudhry, S.N., Schackwitz, W.S., Dent, R., Pennacchio, L.A., McPherson, R. Harper, M.E. 2007. Gain-of-function R225W mutation in human AMPKgamma3 causing increased glycogen and decreased triglyceride in skeletal muscle. PLoS ONE 19, 2, e903.
23. Eguez, L., Lee, A., Chavez, J.A., Miinea, C.P., Kane, S., Lienhard, G.E. McGraw, T.E. 2005. Full intracellular retention of GLUT4 requires AS160 Rab GTPase activating protein. Cell Metab 2, 263 272.
24. El-Mir, M., Nogueira, V., Fontaine, E., Averet, N., Rigoulet, M. Leverve, X. 2000. Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J Biol Chem 275, 223 228.
25. Erion, M.D., van Poelje, P.D., MacKenna, D.A., Colby, T.J., Montag, A.C., Fujitaki, J.M., Linemeyer, D.L. Bullough, D.A. 2004. Liver-targeted drug delivery using HepDirect prodrugs. J Pharmacol Exp Ther 312, 554 560.
26. Foretz, M., Ancellin, N., Andreelli, F., Saintillan, Y., Grondin, P., Kahn, A., Thorens, B., Vaulont, S. Viollet, B. 2005. Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver. Diabetes 54, 1331 1339.
27. Fryer, L.G., Parbu-Pate, A. Carling, D. 2002. The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J Biol Chem 277, 25226 25232.
28. Fujii, N., Hayashi, T., Hirshman, M., Smith, J., Habinowski, S., Kaijser, L., Mu, J., Ljungqvist, O., Birnbaum, M., Witters, L., Thorell, A. Goodyear, L.J. 2000. Exercise induces isoform-specific increase in 5′-AMP-activated protein kinase activity in human skeletal muscle. Biochem Biophys Res Commun 273, 1150 1155.
29. Fujiwara, H., Hosokawa, M., Zhou, X., Fujimoto, S., Fukuda, K., Toyoda, K., Nishi, Y., Fujita, Y., Yamada, K., Yamada, Y., Seino, Y. Inagaki, N. 2008. Curcumin inhibits glucose production in isolated mice hepatocytes. Diabetes Res Clin Pract 80, 185 191.
30. Goodyear, L.J., Giorgino, F., Sherman, L.A., Carey, J., Smith, R.J. Dohm, G.L. 1995. Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest 95, 2195 2204.
31. Göransson, O., McBride, A., Hawley, S.A., Ross, F.A., Shpiro, N., Foretz, M., Viollet, B., Hardie, D.G. Sakamoto, K. 2007. Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase. J Biol Chem 282, 32549 32560.
32. Grundy, S.M. 1998. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. Am J Cardiol 81, 18B 25B.
33. Hardie, D.G. 2007. AMP-activated protein kinase as a drug target. Annu Rev Pharmacol Toxicol 47, 185 210.
34. Hawley, S.A., Boudeau, J., Reid, J.L., Mustard, K.J., Udd, L., Mäkelä, T.P., Alessi, D.R. Hardie, D.G. 2003. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol 2, 28.
35. Hawley, S.A., Pan, D.A., Mustard, K.J., Ross, L., Bain, J., Edelman, A.M., Frenguelli, B.G. Hardie, D.G. 2005. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab 2, 9 19.
36. Hayashi, T., Hirshman, M.F., Kurth, E.J., Winder, W.W. Goodyear, L.J. 1998. Evidence for 5′ AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 47, 1369 1373.
37. Henin, N., Vincent, M., Gruber, H.E. van den Berghe, G. 1995. Inhibition of fatty acid and cholesterol synthesis by stimulation of AMP-activated protein kinase. FASEB J 9, 541 546.
38. Holmes, B.F., Kurth-Kraczek, E.J. Winder, W.W. 1999. Chronic activation of 5′-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle. J Appl Physiol 87, 1990 1995.
39. Horton, J.D., Goldstein, J.L. Brown, M.S. 2002. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109, 1125 1131.
40. Hundal, R.S., Krssak, M., Dufour, S., Laurent, D., Lebon, V., Chandramouli, V., Inzucchi, S.E., Schumann, W.C., Petersen, K.F., Landau, B.R. Shulman, G.I. 2000. Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes 49, 2063 2069.
41. 2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J Biol Chem 280, 29060 29066.
42. Hwang, J., Kim, S., Lee, M., Kim, S.H., Yang, H., Kim, M., Kim, H., Ha, J., Kim, M.S. Kwon, D.Y. 2007. Anti-obesity effects of ginsenoside Rh2 are associated with the activation of AMPK signaling pathway in 3T3-L1 adipocyte. Biochem Biophys Res Commun 364, 1002 1008.
43. Hwang, S., Yang, B., Lee, J., Kim, J., Kim, B., Suh, K., Kim, D., Kim, M., Song, H., Park, B. Huh, T. 2008. Isodihydrocapsiate stimulates plasma glucose uptake by activation of AMP-activated protein kinase. Biochem Biophys Res Commun 371, 289 293.
44. Iglesias, M.A., Ye, J.M., Frangioudakis, G., Saha, A.K., Tomas, E., Ruderman, N.B., Cooney, G.J. Kraegen, E.W. 2002. AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats. Diabetes 51, 2886 2894.
45. Jäger, S., Handschin, C., St-Pierre, J. Spiegelman, B.M. 2007. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc Natl Acad Sci USA 104, 12017 12022.
46. Kawaguchi, T., Osatomi, K., Yamashita, H., Kabashima, T. Uyeda, K. 2002. Mechanism for fatty acid "sparing" effect on glucose-induced transcription: regulation of carbohydrate-responsive element-binding protein by AMP-activated protein kinase. J Biol Chem 277, 3829 3835.
47. Kelley, D.E., Goodpaster, B., Wing, R.R. Simoneau, J.A. 1999. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol 277, E1130 E1141.
48. Kelley, D.E., He, J., Menshikova, E.V. Ritov, V.B. 2002. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51, 2944 2950.
49. Kim, Y.B., Nikoulina, S.E., Ciaraldi, T.P., Henry, R.R. Kahn, B.B. 1999. Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes. J Clin Invest 104, 675 676.
50. Kim, Y.D., Park, K.G., Lee, Y.S., Park, Y.Y., Kim, D.K., Nedumaran, B., Jang, W.G., Cho, W.J., Ha, J., Lee, I.K., Lee, C.H. Choi, H.S. 2007. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP. Diabetes 57, 306 314.
51. Koh, E.H., Kim, M.S., Park, J.Y., Kim, H.S., Youn, J.Y., Park, H.S., Youn, J.H. Lee, K.U. 2003. Peroxisome proliferator-activated receptor (PPAR)-alpha activation prevents diabetes in OLETF rats: comparison with PPAR-gamma activation. Diabetes 52, 2331 2337.
52. Koistinen, H.A., Galuska, D., Chibalin, A.V., Yang, J., Zierath, J.R., Holman, G.D. Wallberg-Henriksson, H. 2003. 5-amino-imidazole carboxamide riboside increases glucose transport and cell-surface GLUT4 content in skeletal muscle from subjects with type 2 diabetes. Diabetes 52, 1066 1072.
53. Koo, S.H., Flechner, L., Qi, L., Zhang, X., Screaton, R.A., Jeffries, S., Hedrick, S., Xu, W., Boussouar, F., Brindle, P., Takemori, H. Montminy, M. 2005. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 437, 1109 1111.
54. Kosaka, T., Okuyama, R., Sun, W., Ogata, T., Harada, J., Araki, K., Izumi, M., Yoshida, T., Okuno, A., Fujiwara, T., Ohsumi, J. Ichikawa, K. 2005. Identification of molecular target of AMP-activated protein kinase activator by affinity purification and mass spectrometry. Anal Chem 77, 2050 2055.
55. Krssak, M., Petersen, K.F., Dresner, A., DiPietro, L., Vogel, S.M., Rothman, D.L., Roden, M. Shulman, G.I. 1999. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 42, 113 116.
56. Kubota, N., Terauchi, Y., Kubota, T., Kumagai, H., Shinsuke, I., Satoh, H., Yano, W., Ogata, H., Tokuyama, K., Takamoto, I. et al. 2006. Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways. J Biol Chem 281, 8748 8755.
57. LeBrasseur, N.K., Kelly, M., Tsao, T., Farmer, S.R., Saha, A.K., Ruderman, N.B. Tomas, E. 2006. Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues. Am J Physiol Endocrinol Metab 291, E175 E181.
58. Lee, Y.S., Kim, W.S., Kim, K.H., Yoon, M.J., Cho, H.J., Shen, Y., Ye, J., Lee, C.H., Oh, W.K., Kim, C.T., Hohnen-Behrens, C., Gosby, A., Kraegen, E.W., James, D.E. Kim, J.B. 2006. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 55, 2256 2264.
59. Liu, G., Grifman, M., MacDonald, J., Moller, P., Wong-Staal, F. Li, Q. 2007. Isoginkgetin enhances adiponectin secretion from differentiated adiposarcoma cells via a novel pathway involving AMP-activated protein kinase. J Endo. 94, 569 578.
60. Lochhead, P.A., Salt, I.P., Walker, K.S., Hardie, D.G. Sutherland, C. 2000. 5-aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase. Diabetes 49, 896 903.
61. Long, Y.C. Zierath, J.R. 2006. AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest 116, 1776 1783.
62. Long, Y.C., Barnes, B.R., Mahlapuu, M., Steiler, T.L., Martinsson, S., Leng, Y., Wallberg-Henriksson, H., Andersson, L. Zierath, J.R. 2005. Role of AMP-activated protein kinase in the coordinated expression of genes controlling glucose and lipid metabolism in mouse white skeletal muscle. Diabetologia 48, 2354 2364.
63. Longus, S.L., Wambolt, R.B., Parsons, H.L., Brownsey, R.W. Allard, M.F. 2003. 5-Aminoimidazole-4-carboxamide 1-beta-d-ribofuranoside (AICAR) stimulates myocardial glycogenolysis by allosteric mechanisms. Am J Physiol Regul Integr Comp Physiol 284, R936 R944.
64. Maeda, N., Takahashi, M., Funahashi, T., Kihara, S., Nishizawa, H., Kishida, K., Nagaretani, H., Matsuda, M., Komuro, R., Ouchi, N., Kuriyama, H., Hotta, K., Nakamura, T., Shimomura, I. Matsuzawa, Y. 2001. PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50, 2094 2099.
65. Matsumoto, M., Han, S., Kitamura, T. Accili, D. 2006. Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. J Clin Invest 116, 2464 2472.
66. McGarry, J.D. Brown, N.F. 1997. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem 244, 1 14.
67. McGuigan, C., Harris, S.A., Daluge, S.M., Gudmundsson, K.S., McLean, E.W., Burnette, T.C., Marr, H., Hazen, R., Condreay, L.D., Johnson, L., De Clercq, E. Balzarini, J. 2005. Application of phosphoramidate pronucleotide technology to abacavir leads to a significant enhancement of antiviral potency. J Med Chem 48, 3504 3515.
68. Merrill, G.F., Kurth, E.J., Hardie, D.G. Winder, W.W. 1997. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am J Physiol 273, E1107 E1112.
69. Moreno, D., Knecht, E., Viollet, B. Sanz, P. 2008. A769662, a novel activator of AMP-activated protein kinase, inhibits non-proteolytic components of the 26S proteasome by an AMPK-independent mechanism. FEBS Lett 582, 2650 2654.
70. Munday, M.R., Campbell, D.G., Carling, D. Hardie, D.G. 1988. Identification by amino acid sequencing of three major regulatory phosphorylation sites on rat acetyl-CoA carboxylase. Eur J Biochem 175, 331 338.
71. Narkar, V.A., Downes, M., Yu, R.T., Embler, E., Wang, Y.X., Banayo, E., Mihaylova, M.M., Nelson, M.C., Zou, Y., Juguilon, H., Kang, H., Shaw, R.J. Evans, R.M. 2008. AMPK and PPARdelta agonists are exercise mimetics. Cell 134, 405 415.
72. Owen, M.R., Doran, E. Halestrap, A.P. 2000. Evidence that metformin exerts its anti-diabetic action through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J 348, 607 614.
73. Pang, T., Zhang, Z., Gu, M., Qiu, B., Yu, L., Cao, P., Shao, W., Su, M., Li, J., Nan, F. Li, J. 2008. Small molecule antagonizes autoinhibition and activates AMP-activated protein kinase in cells. J Biol Chem 283, 16051 16060.
74. Petersen, K.F., Dufour, S., Befroy, D., Garcia, R. Shulman, G.I. 2004. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350, 664 671.
75. Pold, R., Jensen, L.S., Jessen, N., Buhl, E.S., Schmitz, O., Flyvbjerg, A., Fujii, N., Goodyear, L.J., Gotfredsen, C.F., Brand, C.L. Lund, S. 2005. Long-term AICAR administration and exercise prevents diabetes in ZDF rats. Diabetes 54, 928 934.
76. Reznick, R.M. Shulman, G.I. 2006. The role of AMP-activated protein kinase in mitochondrial biogenesis. J Physiol 574, 33 39.
77. Ruderman, N.B., Saha, A.K. Kraegen, E.W. 2003. Minireview: malonyl CoA, AMP-activated protein kinase, and adiposity. Endocrinology 144, 5166 5171.
78. Ryder, J.W., Chibalin, A.V. Zierath, J.R. 2001. Intracellular mechanisms underlying increases in glucose uptake in response to insulin or exercise in skeletal muscle. Acta Physiol Scand 171, 249 257.
79. Saha, A.K., Schwarsin, A.J., Roduit, R., Masse, F., Kaushik, V., Tornheim, K., Prentki, M. Ruderman, N.B. 2000. Activation of malonyl-CoA decarboxylase in rat skeletal muscle by contraction and the AMP-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-beta-d-ribofuranoside. J Biol Chem 275, 24279 24283.
80. Sanders, M.J., Grondin, P.O., Hegarty, B.D., Snowden, M.A. Carling, D. 2007a. Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade. Biochem J 403, 139 148.
81. Sanders, M.J., Ali, Z.S., Hegarty, B.D., Heath, R., Snowden, M.A. Carling, D. 2007b. Defining the mechanism of activation of AMP-activated protein kinase by the small molecule A-769662, a member of the thienopyridone family. J Biol Chem 282, 32539 32548.
82. Shang, J., Chen, L.L., Xiao, F.X., Sun, H., Ding, H.C. Xiao, H. 2008. Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase. Acta Pharmacol Sin 29, 698 706.
83. Shaw, R.J., Lamia, K.A., Vasquez, D., Koo, S.H., Bardeesy, N., Depinho, R.A., Montminy, M. Cantley, L.C. 2005. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310, 1642 1646.
84. Shimomura, I., Matsuda, M., Hammer, R.E., Bashmakov, Y., Brown, M.S. Goldstein, J.L. 2000. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol Cell 6, 77 86.
85. Simoneau, J.A., Colberg, S.R., Thaete, F.L. Kelley, D.E. 1995. Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women. FASEB J 9, 273 278.
86. Steinberg, G.R., Macaulay, S.L., Febbraio, M.A. & Kemp, B.E. 2006. AMP-activated protein kinase - the fat controller of the energy railroad. Can J Physiol Pharmacol 84, 655 665.
87. Storlien, L., Oakes, N.D. Kelley, D.E. 2004. Metabolic flexibility. Proc Nutr Soc 63, 363 368.
88. Suwa, M., Nakano, H. Kumagai, S. 2003. Effects of chronic AICAR treatment on fiber composition, enzyme activity, UCP3, and PGC-1 in rat muscles. J Appl Physiol 95, 960 968.
89. Tan, M., Ye, J., Turner, N., Hohnen-Behrens, C., Ke, C., Tang, C., Chen, T., Weiss, H., Gesing, E., Rowland, A., James, D.E. Ye, Y. 2008. Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway. Chem Biol 15, 263 273.
90. Taskinen, M.R. 2003. Diabetic dyslipidaemia: from basic research to clinical practice. Diabetologia 46, 733 749.
91. Towler, M.C. Hardie, D.G. 2007. AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res 16, 328 341.
92. Tunstall, R.J., Mehan, K.A., Wadley, G.D., Collier, G.R., Bonen, A., Hargreaves, M. Cameron-Smith, D. 2002. Exercise training increases lipid metabolism gene expression in human skeletal muscle. Am J Physiol Endocrinol Metab 283, E66 E72.
93. Turner, N., Li, J., Gosby, A., To, S.W.C., Cheng, Z., Miyoshi, H., Taketo, M.M., Cooney, G.J., Kraegen, E.W., James, D.E., Hu, L., Li, J. Ye, J. 2008. Berberine and its more biologically available derivative dihydroberberine, inhibit mitochondrial respiratory complex I. A mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action. Diabetes 57, 1414 1418.
94. Vaccher, M., Charton, J., Guelzim, A., Caignard, D., Bonte, J. Vaccher, C. 2008. Preparative enantiomeric separation of potent AMP-activated protein kinase activators by HPLC on amylose-based chiral stationary phase. Determination of enantiomeric purity and assignment of absolute configuration. J Pharmacol Biomed Anal 46, 920 928.
95. Vincent, M.F., Marangos, P.J., Gruber, H.E. Van den Berghe, G. 1991. Inhibition of AICA riboside of gluconeogenesis in isolated rat hepatocytes. Diabetes 40, 1259 1266.
96. Winder, W.W., Wilson, H.A., Hardie, D.G., Rasmussen, B.B., Hutber, C.A., Call, G.B., Clayton, R.D., Conley, L.M., Yoon, S. Zhou, B. 1997. Phosphorylation of rat muscle acetyl-CoA carboxylase by AMP-activated protein kinase and protein kinase A. J Appl Physiol 82, 219 225.
97. Winder, W.W., Holmes, B.F., Rubink, D.S., Jensen, E.B., Chen, M. Holloszy, J.O. 2000. Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. J Appl Physiol 88, 2219 2226.
98. Winder, W.W., Taylor, E.B. Thomson, D.M. 2006. Role of AMP-activated protein kinase in the molecular adaptation to endurance exercise. Med Sci Sports Exerc 38, 1945 1949.
99. Wojtaszewski, J.F.P., Birk, J.B., Frosig, C., Holten, M., Pilegaard, H. Dela, F. 2005. 5′AMP activated protein kinase expression in human skeletal muscle: effects of strength training and type 2 diabetes. J Physiol 564, 563 573.
100. Woods, A., Johnstone, S.R., Dickerson, K., Leiper, F.C., Fryer, L.G., Neumann, D., Schlattner, U., Wallimann, T., Carlson, M. Carling, D. 2003. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol 13, 2004 2008.
101. 2+/calmodulin- dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab 2, 21 33.
102. Wright, K.S., Beck-Nielsen, H., Kolterman, O.G. Mandarino, L.J. 1998. Decreased activation of skeletal muscle glycogen synthase by mixed-meal ingestion in NIDDM. Diabetes 37, 436 440.
103. Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R.C. Spiegelman, B.M. 1999. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98, 115 124.
104. Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K. et al. 2002. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8, 1288 1295.
105. Yoon, H., Oh, Y.T., Lee, J.Y., Choi, J.H., Lee, J.H., Baik, H.H., Kim, S.S., Choe, W., Yoon, K., Ha, J. Kang, I. 2008. Activation of AMP-activated protein kinase by kainic acid mediates brain-derived neurotrophic factor expression through a NF-kappaB dependent mechanism in C6 glioma cells. Biochem Biophys Res Commun 371, 495 500.
106. Young, M.E., Radda, G.K. Leighton, B. 1996. Activation of glycogen phosphorylase and glycogenolysis in rat skeletal muscle by AICAR - an activator of AMP-activated protein kinase. FEBS Lett 382, 43 47.
107. Yu, X., McCorkle, S., Wang, M., Lee, E.Y., Li, J., Saha, A.K., Unger, R.H. Ruderman, N.B. 2004. Leptinomimetic effects of the AMP kinase activator AICAR in leptin-resistant rats: prevention of diabetes and ectopic lipid deposition. Diabetologia 47, 2012 2021.
108. Zang, M., Xu, S., Maitland-Toolan, K.A., Zuccollo, A., Hou, X., Jiang, B., Wierzbicki, M., Verbeuren, T.J. Cohen, R.A. 2006. Polyphenols stimulate AMP-activated protein kinase, lower lipids and inhibit accelerated atherosclerosis in diabetic LDL receptor deficient mice. Diabetes 55, 2180 2191.
109. Zhang, F., Sun, C., Wu, J., He, C., Ge, X., Huang, W., Zou, Y., Chen, X., Qi, W. Zhai, Q. 2008. Combretastatin A-4 activates AMP-activated protein kinaseand improves glucose metabolism in db/db mice. Pharm Res 57, 318 323.
110. Zhao, G., Iyengar, R.R., Judd, A.S., Cool, B., Chiou, W., Kifle, L., Frevert, E., Sham, H. Kym, P.R. 2007. Discovery and SAR development of thienopyridones: a class of small molecule AMPK activators. Bioorg Med Chem Lett 17, 3254 3257.
111. Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., Musi, N., Hirshman, M.F., Goodyear, L.J. Moller, D.E. 2001. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108, 1167 1174.
112. Zong, H., Ren, J.M., Young, L.H., Pypaert, M., Mu, J., Birnbaum, M.J. Shulman, G.I. 2002. AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc Natl Acad Sci USA 99, 15983 15987.